Application for quotation of securities - NUZ

Sep 9, 2026 at 7:18 PM EDT · Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · Sep 9, 2026 at 7:18 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-nuz

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 6Announcement SummaryEntity nameNEURIZON THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementThursday September 10, 2026The +securities to be quoted are:Total...

View Attachment

6ix hasn’t read this filing yet.

Neurizon Therapeutics Limited on 6ix

Earlier from Neurizon Therapeutics

NIH funds Expanded Access Program for NUZ-001 in ALSSep 8
Neurizon Appoints Chief Executive OfficerSep 6
Appendix 4E and 2026 Annual ReportAug 25
Appendix 4G and Corporate Governance StatementAug 25
Notification regarding unquoted securities - NUZAug 24

Later from Neurizon Therapeutics

Neurizon Announces Partial Redemption of Convertible NotesSep 9
Notification of cessation of securities - NUZSep 15
Change of Director's Interest NoticeSep 16
Dr Chris Bremer commences as Neurizon CEOSep 30
FDA Type C Feedback, HEALEY trial potentially registrationalOct 5

All Neurizon Therapeutics news releases

Follow Neurizon Therapeutics into a list and get an email when it puts out news.

Follow Neurizon Therapeutics